Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs iShares Core High Dividend ETF (HDV) Price & Performance

CVS Health CorpTrade
iShares Core High Dividend ETFTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs iShares Core High Dividend ETF — how do they compare? CVS Health Corp trades at $104.32 (market cap $135.48B), while iShares Core High Dividend ETF trades at $27.6. The key difference: CVS Health Corp pays a 2.51% dividend while iShares Core High Dividend ETF pays none. Which is the better fit depends on your goals.

CVSHDV
Market Cap
$135.48B
Sector
Health
52-Week High
$106.18$28.09
52-Week Low
$58.75$23.63
Enterprise Value
$202.02B
Dividend Yield
2.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.

The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.

iShares Core High Dividend ETF

HDV (iShares Core High Dividend ETF) trades at $27.93, up 0.83% with a bullish technical signal from moving averages. The ETF focuses on high-quality U.S. dividend stocks with a 3.0% yield, emphasizing defensive sectors like healthcare and energy. Recent performance shows strong total returns with lower volatility than the S&P 500, supported by a 1:5 stock split executed in April 2026.

HDV offers attractive income generation with quality screening, though its concentrated energy exposure (21.56%) introduces sector-specific volatility. The ETF's low expense ratio and defensive positioning provide stability, but investors should monitor oil price sensitivity. Long-term dividend growth potential remains favorable amid current market conditions.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS

About iShares Core High Dividend ETF

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.

Read more on HDV